BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22867996)

  • 1. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
    Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
    Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
    Przybylski GK; Dik WA; Wanzeck J; Grabarczyk P; Majunke S; Martin-Subero JI; Siebert R; Dölken G; Ludwig WD; Verhaaf B; van Dongen JJ; Schmidt CA; Langerak AW
    Leukemia; 2005 Feb; 19(2):201-8. PubMed ID: 15668700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
    Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
    Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
    Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
    Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
    Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K
    Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
    Grabarczyk P; Przybylski GK; Depke M; Völker U; Bahr J; Assmus K; Bröker BM; Walther R; Schmidt CA
    Oncogene; 2007 May; 26(26):3797-810. PubMed ID: 17173069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion.
    Oliveira JL; Kumar R; Khan SP; Law ME; Erickson-Johnson M; Oliveira AM; Ketterling RP; Dogan A
    Pediatr Blood Cancer; 2011 Mar; 56(3):467-9. PubMed ID: 21225930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia.
    Saitou M; Sugimoto J; Hatakeyama T; Russo G; Isobe M
    Oncogene; 2000 May; 19(23):2796-802. PubMed ID: 10851082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4.
    Kawamata N; Sakajiri S; Sugimoto KJ; Isobe Y; Kobayashi H; Oshimi K
    Oncogene; 2002 Jul; 21(32):4983-91. PubMed ID: 12118377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
    Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
    Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.
    Kurosawa N; Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Isobe M
    PLoS One; 2013; 8(1):e55147. PubMed ID: 23383087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
    Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
    Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.
    Kamimura K; Ohi H; Kubota T; Okazuka K; Yoshikai Y; Wakabayashi Y; Aoyagi Y; Mishima Y; Kominami R
    Biochem Biophys Res Commun; 2007 Apr; 355(2):538-42. PubMed ID: 17306224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel fusion genes with 28S ribosomal DNA in hematologic malignancies.
    Kobayashi S; Taki T; Nagoshi H; Chinen Y; Yokokawa Y; Kanegane H; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
    Int J Oncol; 2014 Apr; 44(4):1193-8. PubMed ID: 24504345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
    Tagawa H; Miura I; Suzuki R; Suzuki H; Hosokawa Y; Seto M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):175-85. PubMed ID: 11979551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
    Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
    Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
    MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
    Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(3;14)(p14;q32) results in aberrant expression of FOXP1 in a case of diffuse large B-cell lymphoma.
    Fenton JA; Schuuring E; Barrans SL; Banham AH; Rollinson SJ; Morgan GJ; Jack AS; van Krieken JH; Kluin PM
    Genes Chromosomes Cancer; 2006 Feb; 45(2):164-8. PubMed ID: 16252263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.